Nariman Mehta

Source: Wikipedia, the free encyclopedia.
Nariman Bomanshaw Mehta
GlaxoSmithKline

Nariman Bomanshaw Mehta (April 20, 1920 – August 22, 2014)

Wellbutrin as an antidepressant and smoking cessation aid.[2]

Early life and education

Mehta was born in

Bombay, from where he received Bachelor of Science degrees in chemistry and physics and Bachelor of Arts degrees in English and economics, and a Master of Science degree. In 1939, he and fellow student Kaikhosrov D. Irani, later a noted academic in his own right, wrote and published a Textbook of Theoretical and Practical Physics.[3]

Mehta won a Tata Scholarship and received a grant from

The University of Kansas.[citation needed] Mehta's 1952 dissertation was titled I. Use of the Hammett equation in the prediction of product ratios in the Schmidt reaction of unsymmetrical diarylethylenes: II. The synthesis of possible emetine intermediates.[4]

He had two daughters and a son.[citation needed]

Career

GlaxoSmithKline, where he worked on potential neuropsychopharmacological drugs and designed, synthesized, and patented (in 1969) the compound Bupropion (BW 323U66) that was approved for use as an antidepressant in 1985 and sold under the trade name Wellbutrin. Another application of the drug was as a smoking cessation aid.[5]

Selected publications

Notes

  1. ^ a b "Nariman Bomanshaw Mehta: Obituary". Times-News. Burlington, North Carolina. August 23, 2014. Retrieved November 20, 2014.
  2. ^ U.S. patent 3,819,706
  3. ^ Irani K.D. and Mehta N.B. (1942) "Theoretical and Practical Physics"
  4. OCLC 55019928
    .
  5. ^ van Setten, Henk. "1985: Want a Zyban?". The history of mental health. Retrieved 29 November 2014.

References